Next-generation sequencing technologies can be used to analyse genetically heterogeneous samples at unprecedented detail. The high coverage achievable with these methods enables the detection of many low-frequency variants. However, sequencing errors complicate the analysis of mixed populations and result in inflated estimates of genetic diversity. We developed a probabilistic Bayesian approach to minimize the effect of errors on the detection of minority variants. We applied it to pyrosequencing data obtained from a 1.5‐kb-fragment of the HIV-1 gag/pol gene in two control and two clinical samples. The effect of PCR amplification was analysed. Error correction resulted in a two- and five-fold decrease of the pyrosequencing base substitution...
Massively parallel sequencing (MPS) technologies, such as 454-pyrosequencing, allow for the identifi...
The diversity of virus populations within single infected hosts presents a major difficulty for the ...
Background: With an estimated 38 million people worldwide currently infected with human immunodefici...
Next-generation sequencing technologies can be used to analyse genetically heterogeneous samples at ...
Next-generation sequencing technologies can be used to analyse genetically heterogeneous samples at ...
HIV-1 is a virus with a very variable genome and therefore has the ability to adapt to new environme...
Next-generation sequencing (NGS) is a valuable tool for the detection and quantification of HIV-1 va...
Next-generation sequencing (NGS) is a valuable tool for the detection and quantification of HIV-1 va...
Background: With an estimated 38 million people worldwide currently infected with human immunodefici...
<div><p>454 pyrosequencing, a massively parallel sequencing (MPS) technology, is often used to study...
454 pyrosequencing, a massively parallel sequencing (MPS) technology, is often used to study HIV gen...
Many viruses, including the clinically relevant RNA viruses HIV (human immunodeficiency virus) and H...
Next-generation sequencing (NGS) technologies enable new insights into the diversity of virus popula...
Rapidly evolving RNA viruses prevail within a host as a collection of closely related variants, refe...
Genetic analyses play a central role in infectious disease research. Massively parallelized “mechani...
Massively parallel sequencing (MPS) technologies, such as 454-pyrosequencing, allow for the identifi...
The diversity of virus populations within single infected hosts presents a major difficulty for the ...
Background: With an estimated 38 million people worldwide currently infected with human immunodefici...
Next-generation sequencing technologies can be used to analyse genetically heterogeneous samples at ...
Next-generation sequencing technologies can be used to analyse genetically heterogeneous samples at ...
HIV-1 is a virus with a very variable genome and therefore has the ability to adapt to new environme...
Next-generation sequencing (NGS) is a valuable tool for the detection and quantification of HIV-1 va...
Next-generation sequencing (NGS) is a valuable tool for the detection and quantification of HIV-1 va...
Background: With an estimated 38 million people worldwide currently infected with human immunodefici...
<div><p>454 pyrosequencing, a massively parallel sequencing (MPS) technology, is often used to study...
454 pyrosequencing, a massively parallel sequencing (MPS) technology, is often used to study HIV gen...
Many viruses, including the clinically relevant RNA viruses HIV (human immunodeficiency virus) and H...
Next-generation sequencing (NGS) technologies enable new insights into the diversity of virus popula...
Rapidly evolving RNA viruses prevail within a host as a collection of closely related variants, refe...
Genetic analyses play a central role in infectious disease research. Massively parallelized “mechani...
Massively parallel sequencing (MPS) technologies, such as 454-pyrosequencing, allow for the identifi...
The diversity of virus populations within single infected hosts presents a major difficulty for the ...
Background: With an estimated 38 million people worldwide currently infected with human immunodefici...